Skip to main content

Table 2 Baseline characteristics of the participants by sample

From: A generic outcome assessment of mobility capacity in neurorehabilitation: measurement properties of the de Morton Mobility Index

Characteristic

Validity sample (n = 348)

Reliability sample (n = 133)

Age in years

66 ± 13 (18–90)

66 ± 14 (18–85)

Male/female

218/130 (63/37%)

75/58 (56/44%)

Disease-specific measures

 

Sub-acute stroke: NIH-SS, 0–42 points

5 ± 5 (0–22); n = 109

5 ± 5 (0–22); n = 51

 

Parkinson’s disease: Hoehn and Yahr scale, 0–5 stages

3 (3–4); n = 100

3 (3–4); n = 47

 

Multiple Sclerosis: EDSS, 0–10 grades

6.5 (6–8); n = 18

6.5 (5–8); n = 8

Disease duration,a days

 

mean, SD (range)

30 ± 23 (7–150); n = 173

31 ± 23 (7–118); n = 63

 

median (IQR)

22 (15–38); n = 173

22 (16–37); n = 63

Disease duration,a years

 

mean, SD (range)

11 ± 8 (1–44); n = 175

12 ± 19 (1–44); n = 70

 

median (IQR)

9 (5–14); n = 175

10 (5–16); n = 70

Time since admission at baseline assessment in days

 

mean, SD (range)

7 ± 12 (0–87)

11 ± 15 (0–84)

 

median (IQR)

4 (2–7)

6 (3–12)

Walking aid

 

None

162 (47%)

59 (44%)

 

Rollator/walker

83 (24%)

37 (28%)

 

One cane/stick

25 (7%)

12 (9%)

 

Two crutches/walking sticks

14 (4%)

5 (4%)

 

Not ambulatory/wheelchair

64 (18%)

20 (15%)

de Morton Mobility Index, points

58 ± 26 (0–100)

59 ± 25 (0–100)

  1. NIH-SS National Institutes of Health Stroke Scale, EDSS Expanded Disability Status Scale, SD standard deviation; IQR: interquartile range
  2. Values are mean ± SD (range), median (IQR) or absolute numbers (%)
  3. a Disease duration is reported in days for (sub-acute) conditions with an exact date of event, such as stroke or spinal cord injury. Disease duration is reported in years for chronic conditions such as Parkinson’s disease or Multiple Sclerosis